Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current management of acromegaly.

J J Díez1, P Iglesias

  • 1Department of Endocrinology, Hospital La Paz, Madrid, Spain. mibarsd@infomed-dental.com

Expert Opinion on Pharmacotherapy
|March 16, 2001
PubMed
Summary

Acromegaly, a chronic disease of excess growth hormone (GH), requires early diagnosis. Treatments include surgery, radiation, and medications like somatostatin analogues, which effectively manage GH and IGF-I levels with minimal complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.

Journal of endocrinological investigation·2024
Same author

Computational Model Based on Optical Coherence Tomography (OCT) Skin Scanning to Identify and Quantify Acute Radiation Dermatitis (ARD): A Prospective Diagnostic Study.

Actas dermo-sifiliograficas·2024
Same author

Fungal Planet description sheets: 1383-1435.

Persoonia·2024
Same author

Compartments of the crural fascia: clinically relevant ultrasound, anatomical and histological findings.

Surgical and radiologic anatomy : SRA·2023
Same author

Development and validation of a minimally invasive and image-guided tape stripping method to sample atopic skin in children.

Clinical and experimental dermatology·2023
Same author

Effect of pituitary adenoma consistency on surgical outcomes in patients undergoing endonasal endoscopic transsphenoidal surgery.

Endocrine·2022

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Acromegaly is a chronic condition caused by excess growth hormone (GH) and insulin-like growth factor Type I (IGF-I), often due to pituitary tumors.
  • Early diagnosis and intervention are crucial to prevent long-term health complications.

Purpose of the Study:

  • To review current therapeutic options for acromegaly, including surgery, radiotherapy, and pharmacotherapy.
  • To discuss the efficacy and limitations of various treatment modalities.

Main Methods:

  • Review of existing literature on acromegaly treatments.
  • Analysis of surgical, radiotherapeutic, and pharmacological approaches.
  • Evaluation of dopamine agonists, somatostatin analogues, and emerging therapies.

Main Results:

  • Transsphenoidal adenomectomy is effective, especially for microadenomas, but less so for macroadenomas.
  • Radiotherapy can normalize GH levels over time but carries risks like hypopituitarism.
  • Somatostatin analogues demonstrate significant efficacy in improving symptoms, reducing GH/IGF-I, and decreasing tumor volume, with sustained-release formulations offering improved convenience.
  • Dopamine agonists show modest effects, with newer compounds offering longer action.

Conclusions:

  • Current therapies offer various options for managing acromegaly.
  • Somatostatin analogues, particularly long-acting formulations, represent a significant advancement in treatment.
  • GH receptor antagonists are a promising area for future acromegaly management.

Related Experiment Videos